NCT07244458 Dietary Peanuts and Nutrition-Related Outcomes
| NCT ID | NCT07244458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ian J. Neeland, MD |
| Condition | Dietary Change |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-04-20 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
Eligibility Criteria
Inclusion Criteria: * Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months Exclusion Criteria: * No use or contraindication to use of a GLP-1 RA * Known allergy to nuts * Pregnant or breastfeeding * Incarcerated
Contact & Investigator
Ian Neeland, MD
PRINCIPAL INVESTIGATOR
University Hospitals Cleveland Medical Center
Frequently Asked Questions
Who can join the NCT07244458 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Dietary Change. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244458 currently recruiting?
Yes, NCT07244458 is actively recruiting participants. Contact the research team at Ian.Neeland@UHhospitals.org for enrollment information.
Where is the NCT07244458 trial being conducted?
This trial is being conducted at Clevland, United States.
Who is sponsoring the NCT07244458 clinical trial?
NCT07244458 is sponsored by Ian J. Neeland, MD. The principal investigator is Ian Neeland, MD at University Hospitals Cleveland Medical Center. The trial plans to enroll 64 participants.